Pediatric COVID-19 cases are up 16% in a week and up 41% in the last three weeks. Across the country, vaccination requirement deadlines approach for students.
WATCH FULL EPISODES OF WORLD NEWS TONIGHT:
https://abc.com/shows/world-news-tonight
WATCH WORLD NEWS TONIGHT ON HULU:
https://bit.ly/3iQLwPp
El Dr. Elmer Huerta, asesor médico de RPP, nos explica más sobre el estudio peruano que investiga la presencia del coronavirus en alimentos y superficies.
A declassified U.S. intelligence report says that a natural origin and a lab leak were both possible hypotheses to explain how SARS-CoV-2, the virus responsible for COVID-19, first infected humans, but that the truth may never be known. CBS News intelligence and national security reporter Olivia Gazis joins CBSN AM with details.
CBSN is CBS News’ 24/7 digital streaming news service featuring live, anchored coverage available for free across all platforms. Launched in November 2014, the service is a premier destination for breaking news and original storytelling from the deep bench of CBS News correspondents and reporters. CBSN features the top stories of the day as well as deep dives into key issues facing the nation and the world. CBSN has also expanded to launch local news streaming services in major markets across the country. CBSN is currently available on CBSNews.com and the CBS News app across more than 20 platforms, as well as the Paramount+ subscription service.
Subscribe to the CBS News YouTube channel: http://youtube.com/cbsnews
Watch CBSN live: http://cbsn.ws/1PlLpZ7c
Download the CBS News app: http://cbsn.ws/1Xb1WC8
Follow CBS News on Instagram: https://www.instagram.com/cbsnews/
Like CBS News on Facebook: http://facebook.com/cbsnews
Follow CBS News on Twitter: http://twitter.com/cbsnews
Subscribe to our newsletters: http://cbsn.ws/1RqHw7T
Try Paramount+ free: https://bit.ly/2OiW1kZ
For video licensing inquiries, contact: licensing@veritone.com Video Rating: / 5
DAY TO DAY SYMPTOMS OF COVID-19
Before proceeding, please note that this general overview is compiled for initial self-assessment only and may vary for each individual. If you’re not feeling well, you should immediately consult a medical practitioner to have an accurate diagnosis and proper treatment of COVID-19.
The typical daily symptoms are concluded from the study of 138 patients at Zhongnan Hospital of Wuhan University and another study involving 135 patients from Jinyintan Hospital and 56 patients from Wuhan Pulmonary Hospital.
These symptoms are broken down into:
DAY 1 TO DAY 2
The beginning symptoms are similar to the common cold with a mild sore throat and neither having a fever nor feeling tired. Patients can still consume food and drink as usual.
DAY 3
The patient’s throats start to feel a bit painful. Body temperature reads at around 36.5° celsius. Although it’s uncommon, other symptoms like mild nausea, vomiting or mild diarrhea are possible to set in.
DAY 4
Throat pain becomes more serious. Other symptoms like feeling weak and joint pain start to manifest. The patient may show a temperature reading between 36.5° to 37° celsius.
DAY 5 TO 6
Mild fever starts. The patients show a temperature reading above 37.2° celsius. The second most common symptom, dry cough, also appears. Dyspnea or breathing difficulty may occur occasionally. Most patients in this stage are easily feeling tired. Other symptoms remain about the same. These four symptoms are among the top five key indications of COVID-19 according to the final report of the initial outbreak conducted by the joint mission of China and WHO.
DAY 7
The patients that haven’t started recovering by day 7 get more serious coughs and breathing difficulty. Fever can get higher up to 38° celsius. Patients may develop further headache and body pain or worsening diarrhea if there’s any. Many patients are admitted to the hospital at this stage.
DAY 8 TO 9
On the 8th day, the symptoms are likely to be worsened for the patient who has coexisting medical conditions. Severe shortness of breath becomes more frequent. Temperature reading goes well above 38°. In one of the studies, day 9 is the average time when Sepsis starts to affect 40% of the patients.
DAY 10 TO 11
Doctors are ordering imaging tests like chest x-ray to capture the severity of respiratory distress in patients. Patients are having loss of appetite and may be facing abdominal pain. The condition also needs immediate treatment in ICU.
DAY 12 TO 14
For the survivors, the symptoms can be well-managed at this point. Fever tends to get better and breathing difficulties may start to cease on day 13. But Some patients may still be affected by mild cough even after hospital discharge.
DAY 15 TO 16
Day 15 is the opposite condition for the rest of the minority patients . The fragile group must prepare for the possibility of acute cardiac injury or kidney injury.
DAY 17 TO 19
COVID-19 fatality cases happen at around day 18. Before the time, vulnerable patients may develop a secondary infection caused by a new pathogen in the lower respiratory tract. The severe condition may then lead to a blood coagulation and ischemia.
DAY 20 TO 22
The surviving patients are recovered completely from the disease and are discharged from the hospital.
Subscribe to our YouTube channel for free here:
https://sc.mp/subscribe-youtube
Countries around the world are ramping up efforts to vaccinate their populations in a race to achieve herd immunity against the SARS-CoV-2 virus. As of March 2021, there are about nine leading vaccines used across various countries and regions, each relying on different forms of technology to trigger an immune response in the body to fight the coronavirus. But what exactly goes into each vial? How different are the components? Here’s what you need to know about the ingredients that make up the vaccines against Covid-19.
Support us:
https://subscribe.scmp.com
Follow us on:
Website: https://www.scmp.com
Facebook: https://facebook.com/scmp
Twitter: https://twitter.com/scmpnews
Instagram: https://instagram.com/scmpnews
Linkedin: https://www.linkedin.com/company/south-china-morning-post/
Coronavirus latest – A PILL that Brits could take at home to protect them from serious Covid illness have been approved.
The UK’s drugs regulator on Thursday declared Molnupiravir as “safe and effective” at slashing hospitalisations and deaths in people who have caught the killer bug.
In a release today, the MHRA, said: “Molnupiravir has been authorised for use in people who have mild to moderate Covid-19 and at least one risk factor for developing severe illness.
“Such risk factors include obesity, older age (+60 years), diabetes mellitus, or heart disease.”
Health Secretary Sajid Javid said: “Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral that can be taken at home for Covid-19.
“This will be a gamechanger for the most vulnerable and the immunosuppressed, who will soon be able to receive the ground-breaking treatment.
“We are working at pace across the government and with the NHS to set out plans to deploy molnupiravir to patients through a national study as soon as possible.
“This antiviral will be an excellent addition to our armoury against Covid-19, and it remains vital everyone comes forward for their life-saving Covid-19 vaccine – particularly those eligible for a booster – to ensure as many people as possible are protected over the coming months.”
Continue reading
First oral at-home ‘game changer’ Covid pill that ‘slashes death risk’ gets green light for use on NHS
https://www.thesun.co.uk/health/16632168/covid-drug-slashes-death-risk-nhs/
The Sun newspaper brings you the latest breaking news videos and explainers from the UK and around the world
Become a Sun Subscriber and hit the bell to be the first to know
Read The Sun: http://www.thesun.co.uk
Like The Sun on Facebook: https://www.facebook.com/thesun/
Follow The Sun on Twitter: https://twitter.com/TheSun
Subscribe to The Sun on Snapchat: https://www.snapchat.com/discover/The_Sun/1633225139
Compensation Disclosure
This site receives compensation for referred sales of some or all mentioned products.